BAKER BROS. ADVISORS LP
Q1 2020 13F-HR Holdings
Net value change ($000)
-2,573,621
(-13.7%)
New positions
18
Sold out positions
7
Turnover %
0.8%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2019
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| IGM Biosciences, Inc. | 56,561 | 47.1% |
| Seagen Inc. | 56,406 | 1.0% |
| ACAD | 22,710 | 1.3% |
| CERS | 18,401 | 40.6% |
| Principia Biopharma Inc. | 18,168 | 18.5% |
| KNSA | 12,374 | 40.0% |
| ADAPY | 10,038 | NEW |
| APLS | 8,802 | 57.8% |
| ALEC | 6,756 | NEW |
| BIODELIVERY SCIENCES INTERNATIONAL INC | 6,209 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| AMARIN CORP PLC | -601,622 | -81.3% |
| ONC | -502,301 | -25.7% |
| INCY | -450,415 | -16.1% |
| KOD | -242,747 | -30.5% |
| EXAS | -132,058 | -55.2% |
| ALXN | -106,478 | -11.9% |
| DBVT | -99,085 | -63.4% |
| ASND | -89,876 | -19.1% |
| HRTX | -70,772 | -50.0% |
| Mirati Therapeutics, Inc. | -60,078 | -35.7% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|